Tomoyuki Mizuno, PhD
Associate Professor
Director, Pharmacometric Services
Director, Clinical Pharmacokinetics Consultation Service

The overarching goal of my lab is to facilitate and improve optimal personalized use of medications in children by using PK / PD principles and quantitative approaches with data-driven and mechanism-based mathematical modeling and simulation of drug response.

View Tomoyuki Mizuno, PhD's full bio.

Kei Irie, PhD
Research Associate

I am a research associate specializing in pharmacometrics in the Division of Translational and Clinical Pharmacology. With over ten years of experience as a clinical pharmacist and academic faculty member, I have studied clinical pharmacodynamics in clinical practice. I implement PK/PD modeling and machine learning models for model-informed precision dosing and model-informed drug development.

Sanjana Parikh, MS
PhD Student, UC James L. Winkle College of Pharmacy

I am a second-year PhD student working towards my degree in Pharmaceutical Sciences. My research focuses on “Physiological Based Pharmacokinetic Modeling of Vedolizumab in adults and pediatric patient population." As a student, I work with Tomoyuki Mizuno, PhD, my principal investigator in the Division of Translational and Clinical Pharmacology at Cincinnati Children's for my PhD research.

Wen Rui Tan, MS
PhD Student, Department of Pharmacology and Systems Physiology, UC College of Medicine

As a second-year PhD student, my work revolves around population pharmacokinetics and pharmacodynamics (pop-PKPD) modeling. I specialize in nonlinear mixed-effect modeling for precision dosing across diverse medications. Beyond traditional models, I'm also passionate about leveraging advanced machine learning and deep learning to enhance time series data modeling within the pharmaceutical domain. Outside the lab, I enjoy reading, video gaming, and racket sports.

Ryota Tanaka, PhD
Visiting Research Scientist
Associate Professor, Department of Clinical Pharmacy, Oita University Hospital

I have been working in the Division of Translational and Clinical Pharmacology as a visiting research scientist since 2022. My main research interests are PBPK modeling of buprenorphine and biologics, model-informed drug development, model-informed precision dosing of sirolimus and mycophenolic acid, and pharmacokinetic analysis of tacrolimus extended-release tablet and belatacept.

Holly Ward
Specialist, Business Development
Program Manager, Pharmacometric Services